Move over, Hugh Laurie: there’s a new Dr. House in town. Harvard Medical School associate professor Marinka Zitnik and her lab announced the development of TxGNN, an artificial intelligence model ...

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

HERSHEY, Pa. — Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United Stated topped $722 billion, a trend that’s expected to continue. Yet, ...

As drug prices continue to rise and the affordability of medicines for patients remains out of reach, finding new and creative solutions that address affordability, while also rewarding innovation, is ...

Findacure, a rare diseases charity based in Cambridge, says repurposing existing drugs to treat rare diseases will improve patient outcomes and save the NHS money. Diseases that affect less than 1 in ...

DeepTarget, a next-gen AI tool, predicts cancer drug targets across tumor types and uncovers hidden mechanisms that enable ...

Glioblastoma, an aggressive brain cancer, has a very poor prognosis. More than 95% of glioblastoma patients die within five years of diagnosis. Glioblastoma has an incidence rate of 3.19 per 100,000 ...

This approach offers an enhanced therapeutic effect with minimal systemic toxicity, addressing one of oncology’s long-standing challenges: how to maximise therapeutic effects on tumours while ...